Join our daily newsletter At The Bell to receive exclusive market insights
Imugene (ASX:IMU) has been the talk of the HotCopper forums today, with the much-followed immune-oncology researcher seeing two more complete responses (and three partial responses) in its azer-cel CAR T phase 1b trials.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
The health care company has been in a halt since Monday morning, leaving its price stationary – for the time being, at least – at 42.5cps.
Also trending is Trigg Minerals (ASX:TMG): The antimony miner upgraded its exploration targets at its Canyon Project in Utah to 12.8 to 15.6 Mt @ 0.75% Sb, containing between 96,000 and 234,000 tonnes antimony.
And, DroneShield Ltd (ASX:DRO) was up +7.2% in lunchtime trade after committing $13 million to further R&D and manufacturing capacity expansions.
The bourse is all but flat, just 4.2pts down. Materials has been up +0.7%.
Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
